Product NewsLife Sciences

Transcreener CD73 assay: Leveraging nucleotide detection to measure adenosine

7 Jun 2020
Transcreener CD73 assay: Leveraging nucleotide detection to measure adenosine

Watch this webinar from Meera Kumar, Senior Scientist at BellBrook Labs, to learn more about CD73 as a target for immunotherapy, including information on how the transcreener CD73 assay was developed and how this assay can be used to help measure adenosine.

Other videos from BellBrook Labs

Links

Transcreener CD73 assay: Leveraging nucleotide detection to measure adenosine